DRAXXIN® (tulathromycin injection) Injectable Solution is an anti-infective approved for the treatment of bovine respiratory disease (BRD) caused by all four major bacterial pathogens, including Mycoplasma bovis and infectious bovine keratoconjunctivitis (pinkeye) in non-lactating beef and dairy cattle (including calves) and veal calves. DRAXXIN is also labeled for the treatment of foot rot. Indications DRAXXIN® Injectable Solution is indicated for the following: treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis; and for the control of respiratory disease in cattle at high risk of developing BRD associated with M. haemolytica, P. multocida, H. somni and Mycoplasma bovis; for the treatment of infectious bovine keratoconjunctivitis (pinkeye) associated with Moraxella bovis; and for the treatment of interdigital necrobacillosis (bovine foot rot) associated with Fusobacterium necrophorum and Porphyromonas levii.